Flora Growth Corp. (NASDAQ:FLGC) Q2 2022 Earnings Conference Call August 15, 2022 4:30 PM ET
Company Participants
Jessie Casner - Chief Marketing Officer
Luis Merchan - President, Chief Executive Officer and Chairman
Jason Warnock - Chief Commercial Officer
Elshad Garayev - Chief Financial Officer
Annabelle Manalo-Morgan - Lead Scientific Advisor
Holly Bell - Vice President, Regulatory Affairs
Jessie Casner
Thank you all for joining today, Flora’s First Half 2022 Call. We are going to get started here in just another minute as we wait for a few more attendees to come in.
Alright, welcome everybody. Welcome to the Flora Growth 2022 Conference Call. My name is Jessie Casner, I am the Chief Marketing Officer at Flora. Please note this conference call is going to be recorded and will be published for viewing shortly after the end of this meeting. Following the initial formal remarks, we will conduct a question-and-answer session. All participants can submit questions via the chat and Q&A function in the webcast. Further instructions will be provided as the Q&A begins.
On the call with me today are Luis Merchan, President, Chief Executive Officer and Chairman of the Board. We have Jason Warnock, Chief Commercial Officer. We have Dr. Annabelle Manalo-Morgan, Member of our Board and Lead Scientific Advisor and our newly appointed Chief Financial Officer, Elshad Garayev.
Today, we will be discussing the results for the first half of 2022. This afternoon, our unaudited financial statements for the 6 months ended June 30, 2022 were filed with the SEC under the cover of a Form 6F and we disseminated our earnings release. Copies of both of those can be found in the Investor Relations section on our website and on EDGAR.
I’d like to remind you that during the call, management’s prepared remarks may contain forward-looking statements which are subject to risks and uncertainties. Likewise, management may make additional forward-looking statements during the Q&A session, which are also subject to risks and uncertainties. Forward-looking statements don’t guarantee future performance and therefore undue reliance shouldn’t be placed upon them. For detailed description of the factors that could cause our actual results or business to differ materially from any forward-looking statements made, please see our Form 20-F filed with the SEC on May 9, 2022. The company undertakes no obligation to publicly correct or update the forward-looking statements made during the presentation to reflect future events or circumstances except as they maybe required under applicable securities law. And finally, please note on the call today, management will refer to non-IFRS financial measurements such as adjusted EBITDA and adjusted EBITDA margin, in which Flora excludes certain expenses from its IFRS financial results.